Autoantigens are self-derived molecules that become recognized by the adaptive immune system after tolerance is lost. They may be intracellular enzymes, nuclear ribonucleoproteins, membrane receptors, structural matrix proteins, microbial-response proteins, or tissue-restricted differentiation antigens. In autoimmune and immune-mediated diseases, the target profile is not simply a diagnostic label; it reflects the tissue compartment exposed to inflammation, the route of antigen presentation, the immunoglobulin class or subclass involved, and the effector mechanisms that translate autoantibody binding into tissue injury. For reagent development, assay design, and mechanistic research, each autoantigen should therefore be considered in relation to its native localization, conformational state, post-translational modification, biological function, and disease-associated epitope pattern.
Celiac disease is an immune-mediated enteropathy triggered by dietary gluten in genetically susceptible individuals, especially those carrying HLA-DQ2 or HLA-DQ8. The disease uniquely combines an environmental antigen, gluten-derived peptides, with a self-enzyme autoantigen, tissue transglutaminase 2. TG2 deamidates glutamine residues in gliadin peptides, improving their binding to HLA-DQ2/DQ8 and intensifying T-cell responses. Autoantibodies to TG2, endomysial structures, and deamidated gliadin peptides are central to serological evaluation. Related targets such as epidermal transglutaminase explain extraintestinal manifestations including dermatitis herpetiformis.
Several recurring mechanisms explain how normally tolerated proteins become immunogenic. Cell stress, apoptosis, necrosis, degranulation, extracellular trap formation, defective clearance of immune complexes, microbial mimicry, and oxidative or enzymatic modification can all increase antigen availability. Once antigen is released or redistributed, antigen-presenting cells process peptides and activate autoreactive T cells. B cells receiving T-cell help undergo clonal expansion, affinity maturation, and class switching, producing antibodies that may serve as biomarkers, pathogenic mediators, or both. The clinical value of an autoantigen depends on antigen quality: recombinant proteins should preserve relevant epitopes, native proteins may retain conformational and post-translational features, and peptide antigens are useful when the dominant epitope is linear and well defined.
Fig. 1 Mechanisms of Immunogenicity in Celiac Disease
The classical and commonly used targets include:
These targets should be selected according to the intended research question, assay platform, desired sensitivity and specificity, sample matrix, and whether the study requires native conformational epitopes, recombinant full-length protein, antigenic domains, or synthetic peptide epitopes.
| Target | Location | Function | Immunological Role |
| Tissue transglutaminase 2 (TG2/TGM2) | Intestinal lamina propria, extracellular matrix, endomysium | Protein crosslinking and deamidation of glutamine residues | Principal autoantigen in celiac disease; IgA anti-TG2 is a key marker |
| Endomysial antigen | Connective tissue around smooth muscle; largely TG2-dependent | Extracellular matrix structure | Classical EMA staining target with high specificity |
| Deamidated gliadin peptides (DGP) | Dietary gluten-derived peptides in intestinal mucosa | Exogenous trigger peptides presented by HLA-DQ2/DQ8 | Important serological antigen, especially in selected pediatric or IgA-deficient contexts |
| Epidermal transglutaminase (TG3/TGM3) | Skin epidermis | Protein crosslinking in cornified envelope formation | Autoantigen in dermatitis herpetiformis associated with celiac disease |
| Actin | Enterocyte cytoskeleton | Cell shape and epithelial integrity | Anti-actin antibodies may correlate with severe villous atrophy |
| HLA-DQ2/DQ8-presented gluten complexes | Antigen-presenting cells in gut mucosa | Peptide presentation to CD4 T cells | Genetic restriction platform required for disease development |
TG2 modifies gluten peptides and becomes a self-antigen. Its enzymatic activity creates deamidated epitopes that are efficiently presented to gluten-specific T cells.
Localization and function: Tissue transglutaminase 2 (TG2/TGM2) is primarily associated with intestinal lamina propria, extracellular matrix, endomysium. Its biological role centers on protein crosslinking and deamidation of glutamine residues. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Principal autoantigen in celiac disease; IgA anti-TG2 is a key marker. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Endomysial antibody reactivity historically identified a tissue pattern later linked to TG2. EMA assays preserve matrix-associated conformational antigen presentation.
Localization and function: Endomysial antigen is primarily associated with connective tissue around smooth muscle; largely tg2-dependent. Its biological role centers on extracellular matrix structure. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Classical EMA staining target with high specificity. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
DGP are not self-antigens but are essential disease-related targets. Their deamidation increases negative charge and HLA binding.
Localization and function: Deamidated gliadin peptides (DGP) is primarily associated with dietary gluten-derived peptides in intestinal mucosa. Its biological role centers on exogenous trigger peptides presented by hla-dq2/dq8. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Important serological antigen, especially in selected pediatric or IgA-deficient contexts. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
TG3 antibodies explain cutaneous immune complex deposition and blistering in dermatitis herpetiformis.
Localization and function: Epidermal transglutaminase (TG3/TGM3) is primarily associated with skin epidermis. Its biological role centers on protein crosslinking in cornified envelope formation. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Autoantigen in dermatitis herpetiformis associated with celiac disease. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Anti-actin responses reflect epithelial damage and cytoskeletal antigen exposure, not the primary initiating mechanism.
Localization and function: Actin is primarily associated with enterocyte cytoskeleton. Its biological role centers on cell shape and epithelial integrity. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Anti-actin antibodies may correlate with severe villous atrophy. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
HLA-DQ2/DQ8 are not autoantigens but determine which gluten peptides activate pathogenic T-cell responses.
Localization and function: HLA-DQ2/DQ8-presented gluten complexes is primarily associated with antigen-presenting cells in gut mucosa. Its biological role centers on peptide presentation to cd4 t cells. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Genetic restriction platform required for disease development. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
References
